Dr Pascale Tomasini
- Specialty
- Oncologist, lung expert
- Hospital
- AP-HM Hôpital Nord (Marseille)
- Latest articles
-
- Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial. (May 20, 2025)
- Amivantamab in Participants with Advanced Non-small Cell Lung Cancer (NSCLC) and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study. (May 16, 2025)
- Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A. (May 1, 2025)
- Antitumor activity of vebreltinib and characterization of clinicogenomic features in solid tumors with MET rearrangements. (Apr 10, 2025)
- [Recommendations for the management of oligometatic NSCLC]. (Mar 1, 2025)